Very early researchStudy completedNCT02190279What this trial is testing18F-DCFBC PET/CT in Prostate CancerWho this might be right forProstatic NeoplasmsProstate Cancer National Cancer Institute (NCI) 116
Not applicableStudy completedNCT06809426What this trial is testingEvaluating the Safety and Efficacy of 177Lu-LNC1011 Injection in a Single-Center, Single-Arm, Open Study in Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Desmoplasia-Resistant Prostate CancerWho this might be right forPSMA PET-Positive Castration-Resistant Prostate Cancer Affiliated Hospital of Jiangnan University 13
Not applicableStudy completedNCT05819606What this trial is testingPositron Emission Radiomics With PSMA Radioligands on Newly Diagnosed Prostate Cancer PatientsWho this might be right forProstate Cancer Fondazione Policlinico Universitario Agostino Gemelli IRCCS 70
Early research (Phase 1)Study completedNCT03822871What this trial is testingA Trial of CTT1403 for Metastatic Castration Resistant Prostate CancerWho this might be right forProstate Cancer Cancer Targeted Technology 17
Early research (Phase 1)Active Not RecruitingNCT06441994What this trial is testingClinical Trial of Targeted Alpha Therapy Using [At-211]PSMA-5 for Prostate CancerWho this might be right forProstate Cancer Osaka University 15
Early research (Phase 1)Study completedNCT00712829What this trial is testingStudy to Evaluate the Safety, Pharmacokinetics, Tissue Distribution, Metabolism and Dosimetry of Two Prostate Cancer Imaging AgentsWho this might be right forProstate Cancer Molecular Insight Pharmaceuticals, Inc. 12
Large-scale testing (Phase 3)Looking for participantsNCT07426055What this trial is testingPRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate CancerWho this might be right forProstate Cancer (Adenocarcinoma)Prostate BrachytherapyStereotactic Body Radiation Therapy (SBRT)+2 more Affidea Nu-med Center of Oncological DIagnostics and Therapy 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT07567521What this trial is testingTRC003 in the Treatment of Patients With Progressive PSMA-positive mCRPCWho this might be right forProstate Cancer C Ray Therapeutics 90
Early research (Phase 1)UnknownNCT06237491What this trial is testingThe Safety and Dosimetry Study of 177Lu-LNC1003 InjectionWho this might be right forMetastatic Castration-resistant Prostate Cancer, mCRPC Yantai LNC Biotechnology Singapore PTE. LTD. 12
Testing effectiveness (Phase 2)UnknownNCT05900973What this trial is testingTrial of Darolutamide as a Prostate-Specific Membrane Antigen (PSMA) Expression Enhancer in Patients With Localized Prostate CancerWho this might be right forProstate Cancer D'Or Institute for Research and Education 19
Testing effectiveness (Phase 2)Looking for participantsNCT05155046What this trial is testing18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation TherapyWho this might be right forLocalized Prostate Cancer National Cancer Institute (NCI) 130
Early research (Phase 1)Active Not RecruitingNCT01140373What this trial is testingAdoptive Transfer of Autologous T Cells Targeted to Prostate Specific Membrane Antigen (PSMA) for the Treatment of Castrate Metastatic Prostate Cancer (CMPC)Who this might be right forProstate Cancer Memorial Sloan Kettering Cancer Center 13
Not applicableActive Not RecruitingNCT06359717What this trial is testingProspective Validation of PSMA-RADSWho this might be right forCancer Prostate Zagazig University 477
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07593079What this trial is testingProstate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate CancerWho this might be right forProstate CancerRecurrent Prostate CancerMetastatic Prostate Cancer+2 more Washington University School of Medicine 20
Testing effectiveness (Phase 2)Ended earlyNCT04085991What this trial is testingTwo TraCer PositROn EmiSSion Tomography ComBination for Efficacy EstimatiOn of Prostate Specific Membrane Antigen Radioligand Therapy in Patients With Metastatic Prostate CancerWho this might be right forProstate CancerProstate AdenocarcinomaProstatic Neoplasms+3 more Sir Mortimer B. Davis - Jewish General Hospital 11
Not applicableEnded earlyNCT04745871What this trial is testingDiagnostic Performance of PSMA PET/CT for Pre-operative Lymph Node Assessment in Intermediate and High-risk Non-metastasic Prostate Cancer (PREOP-PSMA ).Who this might be right forProstate Cancer University Hospital, Brest 112
Testing effectiveness (Phase 2)Ended earlyNCT03463889What this trial is testingGallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid CancerWho this might be right forThyroid Gland Carcinoma University of California, San Francisco 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT05658003What this trial is testingA Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in Taxane Treatment Naive Chinese Male Patients With Progressive Metastatic Castrate Resistant Prostate CancerWho this might be right forMetastatic Castration-Resistant Prostate Cancer (mCRPC) Novartis Pharmaceuticals 63
Early research (Phase 1)Looking for participantsNCT07813637What this trial is testingPhase 1 Trial to Study JANX013 and JANX007 Combination in mCRPCWho this might be right forProstate CancerCastration-Resistant Prostate Cancer (CRPC)Metastatic Prostate Cancer+1 more Janux Therapeutics 110
Testing effectiveness (Phase 2)Study completedNCT01496157What this trial is testingEvaluation of Prostate-specific Membrane Antigen (PSMA)-Based PET Imaging of Primary Prostate CancerWho this might be right forProstate Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15